What is it about?
This study reviewed and evaluated published healthcare or clinical practice guidelines for Attention Deficit Hyperactivity Disorder (short ADHD) that is a common condition affecting people's behavior. The tool used for this evaluation is called the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument (version 2).
Featured Image
Photo by Julia Taubitz on Unsplash
Why is it important?
The AGREE II Instrument is the gold standard for appraising clinical practice guidelines that is recommended by The Enhancing the QUAlity and Transparency Of health Research Network (short EQUATOR Network). It highlighted the published ADHD guidelines of highest quality and evidence base at the time of the study that can guide healthcare providers in selecting the best practice guidelines to manage people with ADHD.
Perspectives
This and similar publications can help in pooling sets of evidence-based and high-quality guidelines into (RECOMMMATION MAPS) for specific diseases and conditions to guide the healthcare teams to provide the best practice and service in terms of the related state-of-the-art science, quality and safety.
Dr. Yasser Sami Amer
King Saud University
Read the Original
This page is a summary of: Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review, PLoS ONE, July 2019, PLOS,
DOI: 10.1371/journal.pone.0219239.
You can read the full text:
Contributors
The following have contributed to this page
